| |
uUTI’s Across a Lifetime | | |
With over half of all women being affected
by UTIs, it is vital to understand how
uncomplicated UTIs can impact women at all
stages of their life and how different
timepoints influence symptomology,
diagnosis, and treatment. Join our industry
experts as they discuss how current
guidelines and treatment algorithms may need
to evolve to consider the life and
experiences of the patient.
| |  ESCMID‑appointed chair: Dr José Molina Gil-Bermejo (Spain) |  GSK-appointed chair: Danielle Powell (UK) |  Dr Annie Joseph (UK) |  Dr Jennifer Kranz (Germany) |  Dr Pamela Kushner (US) | | | | | | | | | |
|
| |
Why does it have to be so complicated?
Patient cases in cUTI | | |
Join our panel of experts as they discuss
the various clinical considerations that
impact patient care in complicated UTI
management. The panel review current and
proposed guideline updates, exploring topics
such as the duration of treatment, fever and
sepsis, the risk of antimicrobial resistance
and empiric antibiotic treatment choices
through a series of illustrative patient
cases.
| |  ESCMID-appointed chair: Dr Gerard Lina (France) |  GSK-appointed chair: Dr Aruni Mulgirigama (UK) |  Dr Juan Pablo Horcajada Gallego (Spain) |  Prof. Keith Kaye (US) |  Dr Erin McCreary (US) |  Prof. Bhaskar Somani (UK) | | | | | | | | | | |
|
| Scientific Symposia: Vaccines | | |
| |
Why your influence counts: shaping adult
vaccination policies and recommendations
with a focus on herpes zoster | | |
Join our industry experts as they explore
the use of real-world data in identifying
populations at risk of infectious diseases
such as herpes zoster and highlight the
pivotal role of infectious disease
specialists in shaping adult vaccination
policies.
| |  ESCMID‑appointed chair: Prof. Dan Barouch (USA) |  Prof. Giovanni Gabutti (Italy) |  Prof. Thea Kølsen Fischer (Denmark) |  Prof. Tino Schwarz (Germany) |  Prof. Pierre Van Damme (Belgium) | | | | | | | | | | |
|
| |
Rethinking the burden of RSV in adults | | |
At present, our knowledge on the burden of
RSV in adults is limited, with RSV infection
often being overlooked in general practice.
Join us as our panel provides an update on
the 2023/2024 RSV season with a spotlight on
patients living with comorbidities and
explore the evolution of RSV surveillance
and testing practices.
| |  ESCMID‑appointed chair: Dr Peng Wu (Hong Kong) |  Dr Alan Kaplan (Canada) |  Dr Iván Sanz Muñoz (Spain) |  Prof. Peter Openshaw (UK) |  Prof. Caterina Rizzo (Italy) | | | | | | | | | | |
|
| Innovation and Pipeline Theatres | | |
| |
Embracing Schrödinger’s cat in the rewriting
of the infectious diseases narrative | | |
By understanding the tools we have at our
disposal and the barriers we face at a
global level we learn how together we can
improve prevention needs and fight AMR.
Prevention and intervention should be seen
as a combined effort.
| |  Dr Souha Kanj (Lebanon) |  Dr Kamran Khan (Canada) | | | | | | | | | | |
|
Find out more about GSK's Infectious Disease portfolio here.
Thanks for joining us for the thought-provoking presentations and discussions.
The content will be live on the ESCMID global platform until 31 October
2024.
We hope to see you again at ESCMID Global 2025!
|
|
|
Our GSK teams look forward to engaging with you in your home
countries. If you would like to find out more or contact your
local team please visit our Medical Affairs portal.
| |
Please do not forward.
|
Scientific dissemination is based on published and accessible data
and has an informative/educational purpose. To this end, the data
is presented faithfully reflecting scientific publications without
any modification or addition. Its content is protected by
copyright and may not be reproduced (photo, recording or 'screen
prints'), nor disclosed or transmitted to any third party by any
means, without the written authorization of GSK.
La divulgación científica está basada en datos publicados y
accesibles y tiene una finalidad informativa/formativa. A tal
efecto, los datos se presentan reflejando fielmente las
publicaciones científicas sin ninguna modificación o añadido. Su
contenido está protegido por derechos de autor y no puede ser
reproducido (foto, grabación o 'impresiones de pantalla’), ni
divulgado ni transmitido a ningún tercero por cualquier medio, sin
la autorización escrita de GSK.
Scientific symposia, organised and funded by GSK.
©GlaxoSmithKline 2024. All rights reserved GlaxoSmithKline UK
Limited
NX-GBL-CEP-EML-240005 | July 2024
| | |
|
